|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64,500 VND | -0.92% |
|
-6.93% | +13.96% |
Imexpharm Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was VND 1,643,706.51 million compared to VND 1,266,596.71 million a year ago. Net income was VND 233,964.48 million compared to VND 189,094.87 million a year ago.
Basic earnings per share from continuing operations was VND 3,328.5714 compared to VND 2,479.0476 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.96% | 178M | |
| +25.88% | 661B | |
| +26.74% | 566B | |
| -6.78% | 352B | |
| +19.07% | 332B | |
| +3.18% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.25% | 145B |
IMEXPHARM CORPORATION 
